Davinder Kumar

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 15

Top Topics

Molecular Docking

Breast Cancer Cells

Top Venues

Pharmaceuticals (Basel, Switzerland)

Future medicinal chemistry

Therapeutic delivery

This page only lists publications with an associated author ORCID identifier.

Publications

Robel Singh, Pawan Kumar, Davinder Kumar, Navidha Aggarwal, Hitesh Chopra, Virender Kumar
Alopecia areata: review of epidemiology, pathophysiology, current treatments and nanoparticulate delivery system. Therapeutic delivery (2024)
Robel Singh, Pawan Kumar, Davinder Kumar, Navidha Aggarwal, Hitesh Chopra, Virender Kumar
Alopecia areata: review of epidemiology, pathophysiology, current treatments and nanoparticulate delivery system. Therapeutic delivery 15 (3) (2024)
Robel Singh, Pawan Kumar, Davinder Kumar, Navidha Aggarwal, Hitesh Chopra, Virender Kumar
Alopecia areata: review of epidemiology, pathophysiology, current treatments and nanoparticulate delivery system. Therapeutic delivery 15 (3) (2024)
Davinder Kumar, Navidha Aggarwal, Virender Kumar, Inderbir Padda, Rakesh Kumar Marwaha, Rohit Sharma
Emerging synthetic strategies and pharmacological insights of 1,3,4-thiadiazole derivatives: a comprehensive review. Future medicinal chemistry 16 (6) (2024)
Davinder Kumar, Navidha Aggarwal, Virender Kumar, Inderbir Padda, Rakesh Kumar Marwaha, Rohit Sharma
Emerging synthetic strategies and pharmacological insights of 1,3,4-thiadiazole derivatives: a comprehensive review. Future medicinal chemistry (2024)
Davinder Kumar, Navidha Aggarwal, Virender Kumar, Inderbir Padda, Rakesh Kumar Marwaha, Rohit Sharma
Emerging synthetic strategies and pharmacological insights of 1,3,4-thiadiazole derivatives: a comprehensive review. Future medicinal chemistry 16 (6) (2024)
Davinder Kumar, Navidha Aggarwal, Virender Kumar, Inderbir Padda, Rakesh Kumar Marwaha, Rohit Sharma
Emerging synthetic strategies and pharmacological insights of 1,3,4-thiadiazole derivatives: a comprehensive review. Future medicinal chemistry 16 (6) (2024)
Davinder Kumar, Navidha Aggarwal, Harsh Kumar, Garima Kapoor, Aakash Deep, Shabana Bibi, Aastha Sharma, Inderbir Padda, Rakesh Kumar Marwaha, Abdulrahman Alshammari, Metab Alharbi, Abdul Hayee
2-Substituted-3-(5-Substituted-1,3,4-oxadiazol/thiadiazol-2-yl) Thiazolidin-4-one Derivatives: Synthesis, Anticancer, Antimicrobial, and Antioxidant Potential. Pharmaceuticals (Basel, Switzerland) 16 (6) (2023)
Davinder Kumar, Navidha Aggarwal, Virender Kumar, Harsh Kumar, Aakash Deep, Shabana Bibi, Inderbir Padda, Rakesh Kumar Marwaha, Abdulrahman Alshammari, Metab Alharbi, Abdul Hayee
Synthesis, Anticancer, Antimicrobial and Antioxidant Potential of Novel 4-(Substituted phenyl-1,3,4-oxadiazol/thiadiazol-2-yl)-4-(4-substituted phenyl) Azetidin-2-One Derivatives. Pharmaceuticals (Basel, Switzerland) 16 (4) (2023)
Harsh Kumar, Aastha Sharma, Davinder Kumar, Minakshi Gupta Marwaha, Meenakshi Dhanawat, Navidha Aggarwal, Rakesh Kumar Marwaha
Synthesis, biological evaluation and in silico studies of some new analogues of 3,5-disubstituted thiazolidin-2,4-dione. Future medicinal chemistry (2023)
Davinder Kumar, Navidha Aggarwal, Virender Kumar, Harsh Kumar, Aakash Deep, Shabana Bibi, Inderbir Padda, Rakesh Kumar Marwaha, Abdulrahman Alshammari, Metab Alharbi, Abdul Hayee
Synthesis, Anticancer, Antimicrobial and Antioxidant Potential of Novel 4-(Substituted phenyl-1,3,4-oxadiazol/thiadiazol-2-yl)-4-(4-substituted phenyl) Azetidin-2-One Derivatives. Pharmaceuticals (Basel, Switzerland) 16 (4) (2023)
Davinder Kumar, Navidha Aggarwal, Aakash Deep, Harsh Kumar, Inderbir Padda, Rakesh Kumar Marwaha, Daniela Simona Cavalu
An Understanding of Mechanism-Based Approaches for 1,3,4-Oxadiazole Scaffolds as Cytotoxic Agents and Enzyme Inhibitors. Pharmaceuticals (Basel, Switzerland) 16 (2) (2023)
Davinder Kumar, Navidha Aggarwal, Virender Kumar, Harsh Kumar, Aakash Deep, Shabana Bibi, Inderbir Padda, Rakesh Kumar Marwaha, Abdulrahman Alshammari, Metab Alharbi, Abdul Hayee
Synthesis, Anticancer, Antimicrobial and Antioxidant Potential of Novel 4-(Substituted phenyl-1,3,4-oxadiazol/thiadiazol-2-yl)-4-(4-substituted phenyl) Azetidin-2-One Derivatives. Pharmaceuticals (Basel, Switzerland) 16 (4) (2023)
Davinder Kumar, Navidha Aggarwal, Harsh Kumar, Garima Kapoor, Aakash Deep, Shabana Bibi, Aastha Sharma, Inderbir Padda, Rakesh Kumar Marwaha, Abdulrahman Alshammari, Metab Alharbi, Abdul Hayee
2-Substituted-3-(5-Substituted-1,3,4-oxadiazol/thiadiazol-2-yl) Thiazolidin-4-one Derivatives: Synthesis, Anticancer, Antimicrobial, and Antioxidant Potential. Pharmaceuticals (Basel, Switzerland) 16 (6) (2023)
Davinder Kumar, Navidha Aggarwal, Virender Kumar, Harsh Kumar, Aakash Deep, Shabana Bibi, Inderbir Padda, Rakesh Kumar Marwaha, Abdulrahman Alshammari, Metab Alharbi, Abdul Hayee
Synthesis, Anticancer, Antimicrobial and Antioxidant Potential of Novel 4-(Substituted phenyl-1,3,4-oxadiazol/thiadiazol-2-yl)-4-(4-substituted phenyl) Azetidin-2-One Derivatives. Pharmaceuticals (Basel, Switzerland) 16 (4) (2023)